PazhayattilGSBrewsterUCPerazellaMA. A case of crystalline nephropathy. Kidney Int2015; 87(6): 1265–1266.
2.
MallipattuSKRossMJ. Methotrexate in the urine. Kidney Int2011; 80: 226.
3.
MonjanelSRigaultJPCanoJP, et al. High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach. Cancer Chemother Pharmacol1979; 3(3): 189–196.
4.
WidemannBCBalisFMKempf-BielackB, et al. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer2004; 100(10): 2222–2232.
5.
WidemannBCAdamsonPC. Understanding and managing methotrexate nephrotoxicity. Oncologist2006; 11(6): 694–703.
6.
RamseyLBBalisFMO’BrienMM, et al. Consensus guideline for use of glucarpidase in patients with high-dose methotrexate induced acute kidney injury and delayed methotrexate clearance. Oncologist2018; 23(1): 52–61.
7.
AhmadSShenFHBleyerWA. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Arch Intern Med1978; 138(7): 1146–1147.
